ClinicalTrials.Veeva

Menu

Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years (DEKS)

Case Western Reserve University logo

Case Western Reserve University

Status

Begins enrollment in 2 months

Conditions

Corneal Endothelial Decompensation
Fuchs Endothelial Corneal Dystrophy

Treatments

Procedure: Descemet membrane endothelial keratoplasty

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07217249
5UG1EY030030-05 (U.S. NIH Grant/Contract)
1UG1EY037206-01 (U.S. NIH Grant/Contract)
DEKS 5-year Extension Study

Details and patient eligibility

About

This multi-center clinical trial is designed to assess the association of diabetes in a cornea donor with transplant success and loss of endothelial cells 5 years following Descemet membrane endothelial keratoplasty (DMEK). Study eyes are assigned to receive either a cornea from a donor without diabetes or a cornea from a donor with diabetes in a masked fashion.

Enrollment

570 estimated patients

Sex

All

Ages

30 to 93 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Willing to return to the study site for follow up at 3 and 5 years after a Descemet membrane endothelial keratoplasty procedure
  • Fluent in English or Spanish
  • Willing to have fingerstick blood sample collected to determine HbA1c level
  • Participated and completed 12-month follow-up in the DEKS study for one or both eyes or a DEKS participant that had a study eye regraft prior to the 12-month visit.

Exclusion criteria

  • Lack cognitive capacity such that consent could not be provided.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

570 participants in 2 patient groups

Assigned cornea from a donor without diabetes
Active Comparator group
Description:
Eyes assigned to this arm receive a cornea from a donor without diabetes and undergo Descemet membrane endothelial keratoplasty.
Treatment:
Procedure: Descemet membrane endothelial keratoplasty
Assigned cornea from a donor with diabetes
Active Comparator group
Description:
Eyes assigned to this arm receive a cornea from a donor with diabetes for Descemet membrane endothelial keratoplasty.
Treatment:
Procedure: Descemet membrane endothelial keratoplasty

Trial contacts and locations

5

Loading...

Central trial contact

Jonathan Lass, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems